V-5 Immunitor: Phase II data

An open-label, Ukrainian Phase II trial in 20 chronic HCV patients co-infected with HIV and TB showed that once-daily oral

Read the full 202 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE